Novartis Bioventures Ltd 13D and 13G filings for Aerpio Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2020-05-15 06:05 am Sale |
2020-05-13 | 13D | Aerpio Pharmaceuticals, Inc. ARPO |
Novartis Bioventures Ltd | 42,349 1.570% |
-167,495 (-79.82%) |
Filing |